Wearing a revolutionary-era tricorn hat, doctor Mathew Maurer stood at a lectern in front of an audience of fellow cardiologists in Philadelphia, decrying the price of a new medication that had the potential to help many of his heart-failure patients. The drug, Pfizer Inc.’s tafamidis, cost $651 a day, Maurer told them-equal to a patient’s food budget for a month.
Home » Amyloidosis » Doctors who helped develop heart drug now balk at $225,000-a-year price
Doctors who helped develop heart drug now balk at $225,000-a-year price
Rose Duesterwald
Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia four years ago. He was treated with a methylating agent While he was being treated with a hypomethylating agent, Rose researched investigational drugs being developed to treat relapsed/refractory AML.
Share this post
Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email